Abstract
Immune Checkpoint Inhibitor related colitis (“irColitis”) can range in severity from mild symptoms that may self resole with supportive therapy, to life-threatening disease. More severe cases require immunosuppression with corticosteroids or biologic therapies, but there is little evidence about what to do when these agents fail. In this article we present a case of irColitis that was refractory to established pharmacological treatments, but then resolved after introduction of Tacrolimus. Successful treatment of irColitis with Tacrolimus has not previously been reported and so this finding will be significant for future research studies and guidelines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Biomedical Science & Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
